Completed

Impact of Topical, Retrobulbar and General Anesthesia in Ocular Blood Flow

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Eye Diseases+1

+ Glaucoma

+ Ocular Hypertension

Over 18 Years
+6 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Observational
Study Start: February 2013
See protocol details

Summary

Principal SponsorUniversitaire Ziekenhuizen KU Leuven
Last updated: May 29, 2015
Sourced from a government-validated database.Claim as a partner

Study start date: February 1, 2013

Actual date on which the first participant was enrolled.

Ultrasound B-mode scans will be performed before and after the anesthetic procedure Doppler scan will be added to the B-mode ultrasound to register the blood flow pattern of the ophthalmic and central retinal arteries Blood pressure and heart rate will be monitored

Principal SponsorUniversitaire Ziekenhuizen KU Leuven
Last updated: May 29, 2015
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

240 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Eye DiseasesGlaucomaOcular HypertensionGlaucoma, Open-Angle

Criteria

2 inclusion criteria required to participate
individuals over 18 years old

willing to sign an informed consent and able to comply with the requirements of the study

4 exclusion criteria prevent from participating
history of ocular trauma

ocular disease other than the one motivating surgery

previous extraocular surgery

systemic diseases with ocular involvement like diabetes or Graves Ophthalmopathy

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

3 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

KU Leuven

Leuven, BelgiumOpen KU Leuven in Google Maps
CompletedOne Study Center